MONDAY, Feb. 8, 2021 (HealthDay News) — The U.S. Food and Drug Administration on Friday approved the marketing of a new “tongue strengthening” device to cut down on snoring in patients with mild obstructive sleep apnea. Unlike devices used during sleep, this prescription device is used while awake, and isContinue Reading

South Africa Delays AstraZeneca Vaccine Rollout After It Shows Lack of Effectiveness Against COVID Variant Plans to vaccinate frontline health workers with the Oxford-AstraZeneca COVID-19 vaccine have been delayed by South Africa because there are questions about its effectiveness. Preliminary data from a small clinical trial indicate that the vaccineContinue Reading